197 related articles for article (PubMed ID: 31685947)
1. DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals.
Chen X; Xiong X; Cui D; Yang F; Wei D; Li H; Shu J; Bi Y; Dai X; Gong L; Sun Y; Zhao Y
Oncogene; 2020 Feb; 39(7):1557-1571. PubMed ID: 31685947
[TBL] [Abstract][Full Text] [Related]
2. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
3. DEPTOR inhibits lung tumorigenesis by inactivating the EGFR-mTOR signals.
Gong L; Shu J; Chen X; Pan H; Chen G; Bi Y; Cui D; Li X; Liu D; Wang L; Wang Y; Liu P; Xiong X; Zhao Y
Cancer Lett; 2021 Oct; 519():263-276. PubMed ID: 34320372
[TBL] [Abstract][Full Text] [Related]
4. Phosphoproteome Analysis Reveals Estrogen-ER Pathway as a Modulator of mTOR Activity Via DEPTOR.
Cuesta R; Gritsenko MA; Petyuk VA; Shukla AK; Tsai CF; Liu T; McDermott JE; Holz MK
Mol Cell Proteomics; 2019 Aug; 18(8):1607-1618. PubMed ID: 31189691
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal protein S27-like regulates autophagy via the β-TrCP-DEPTOR-mTORC1 axis.
Xiong X; Liu X; Li H; He H; Sun Y; Zhao Y
Cell Death Dis; 2018 Nov; 9(11):1131. PubMed ID: 30425236
[TBL] [Abstract][Full Text] [Related]
6. Differential roles and activation of mammalian target of rapamycin complexes 1 and 2 during cell migration in prostate cancer cells.
Venugopal SV; Caggia S; Gambrell-Sanders D; Khan SA
Prostate; 2020 Apr; 80(5):412-423. PubMed ID: 31995655
[TBL] [Abstract][Full Text] [Related]
7. TGFβ-induced deptor suppression recruits mTORC1 and not mTORC2 to enhance collagen I (α2) gene expression.
Das F; Bera A; Ghosh-Choudhury N; Abboud HE; Kasinath BS; Choudhury GG
PLoS One; 2014; 9(10):e109608. PubMed ID: 25333702
[TBL] [Abstract][Full Text] [Related]
8. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects.
Jhanwar-Uniyal M; Amin AG; Cooper JB; Das K; Schmidt MH; Murali R
Adv Biol Regul; 2017 May; 64():39-48. PubMed ID: 28189457
[TBL] [Abstract][Full Text] [Related]
9. DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma.
Yao H; Tang H; Zhang Y; Zhang QF; Liu XY; Liu YT; Gu WT; Zheng YZ; Shang HB; Wang Y; Huang JY; Wei YX; Zhang X; Zhang J; Wu ZB
Cancer Lett; 2019 Sep; 459():135-144. PubMed ID: 31176743
[TBL] [Abstract][Full Text] [Related]
10. microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression.
Maity S; Bera A; Ghosh-Choudhury N; Das F; Kasinath BS; Choudhury GG
Exp Cell Res; 2018 Mar; 364(1):5-15. PubMed ID: 29397070
[TBL] [Abstract][Full Text] [Related]
11. OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR.
Zhao L; Wang X; Yu Y; Deng L; Chen L; Peng X; Jiao C; Gao G; Tan X; Pan W; Ge X; Wang P
J Biol Chem; 2018 Mar; 293(13):4883-4892. PubMed ID: 29382726
[TBL] [Abstract][Full Text] [Related]
12. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948
[TBL] [Abstract][Full Text] [Related]
13. PUM1 Promotes Tumor Progression by Activating DEPTOR-Meditated Glycolysis in Gastric Cancer.
Yin S; Liu H; Zhou Z; Xu X; Wang P; Chen W; Deng G; Wang H; Yu H; Gu L; Huo M; Li M; Zeng L; He Y; Zhang C
Adv Sci (Weinh); 2023 Sep; 10(27):e2301190. PubMed ID: 37469018
[TBL] [Abstract][Full Text] [Related]
14. DEPTOR Deficiency-Mediated mTORc1 Hyperactivation in Vascular Endothelial Cells Promotes Angiogenesis.
Ding Y; Shan L; Nai W; Lin X; Zhou L; Dong X; Wu H; Xiao M; Zhou X; Wang L; Li T; Fu Y; Lin Y; Jia C; Dai M; Bai X
Cell Physiol Biochem; 2018; 46(2):520-531. PubMed ID: 29614494
[TBL] [Abstract][Full Text] [Related]
15. Dynamic modelling of the mTOR signalling network reveals complex emergent behaviours conferred by DEPTOR.
Varusai TM; Nguyen LK
Sci Rep; 2018 Jan; 8(1):643. PubMed ID: 29330362
[TBL] [Abstract][Full Text] [Related]
16. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the Scaffolding Function of mLST8 Selectively Inhibits mTORC2 Assembly and Function and Suppresses mTORC2-Dependent Tumor Growth
Hwang Y; Kim LC; Song W; Edwards DN; Cook RS; Chen J
Cancer Res; 2019 Jul; 79(13):3178-3184. PubMed ID: 31085701
[TBL] [Abstract][Full Text] [Related]
18. Bipartite binding and partial inhibition links DEPTOR and mTOR in a mutually antagonistic embrace.
Heimhalt M; Berndt A; Wagstaff J; Anandapadamanaban M; Perisic O; Maslen S; McLaughlin S; Yu CW; Masson GR; Boland A; Ni X; Yamashita K; Murshudov GN; Skehel M; Freund SM; Williams RL
Elife; 2021 Sep; 10():. PubMed ID: 34519269
[TBL] [Abstract][Full Text] [Related]
19. Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways.
Cho JH; Kim K; Kim SA; Park S; Park BO; Kim JH; Kim SY; Kwon MJ; Han MH; Lee SB; Park BC; Park SG; Kim JH; Kim S
Cell Death Differ; 2021 Mar; 28(3):900-914. PubMed ID: 33110214
[TBL] [Abstract][Full Text] [Related]
20. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
